# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing SystemOmnicell, Inc. (NASDAQ:...
Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $42 to $38.
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Equal-Weight and lowers the price target from $...
The table below summarizes Omnicell's 2024 guidance outlined above. Q1 2024 ...
Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.15 by 120...
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...
Wells Fargo analyst Stan Berenshteyn upgrades Omnicell (NASDAQ:OMCL) from Underweight to Equal-Weight and lowers the price t...
BTIG analyst David Larsen downgrades Omnicell (NASDAQ:OMCL) from Buy to Neutral.